Invesco Pharmaceuticals ETF

Invesco Pharmaceuticals ETF reported 29 holdings worth US$472M as of Jul 31, 2026 (Form N-PORT)

As of Jul 31, 2026 · Filed Sep 28, 2026

Invesco Pharmaceuticals ETF reported 29 holdings worth US$472M as of Jul 31, 2026. Largest: Abbott Laboratories, Abbvie Inc. and Amgen Inc. Filed Sep 28, 2026 (Form N-PORT).

Holdings
29
Value as reported
US$472M

The filing in full

CompanySharesValue as reported% of portfolio
Abbott Laboratories253KUS$26.8M5.7%
Abbvie Inc.103KUS$25.9M5.5%
Amgen Inc.65,359US$25.2M5.3%
Johnson & Johnson95,373US$24.4M5.2%
Merck & Company, Inc.183KUS$23.9M5.1%
Eli Lilly And Company20,622US$23.7M5.0%
Corcept Therapeutics Incorporated205KUS$23.4M5.0%
Gilead Sciences, Inc.164KUS$21.4M4.5%
Pfizer, Inc.849KUS$21.2M4.5%
Amneal Pharmaceuticals, Inc.966KUS$17.7M3.7%
Liquidia Corporation205KUS$17.3M3.7%
Travere Therapeutics, Inc.279KUS$15.6M3.3%
Ligand Pharmaceuticals Incorporated52,490US$15.1M3.2%
Regeneron Pharmaceuticals, Inc.19,460US$14.8M3.1%
Harmony Biosciences Holdings, Inc.410KUS$14.5M3.1%
Bristol-myers Squibb Company213KUS$13.9M2.9%
Viatris Inc.760KUS$13.3M2.8%
Jazz Pharmaceuticals Plc52,047US$13.2M2.8%
Biogen Inc.63,929US$13M2.7%
Collegium Pharmaceutical, Inc.366KUS$12.9M2.7%
Prestige Consumer Healthcare Inc.257KUS$12.9M2.7%
Ocular Therapeutix, Inc.1.49MUS$12.2M2.6%
Ani Pharmaceuticals, Inc.152KUS$12M2.5%
Tarsus Pharmaceuticals, Inc.202KUS$11.9M2.5%
Perrigo Company Plc1.14MUS$11.6M2.4%
Supernus Pharmaceuticals, Inc.258KUS$11.5M2.4%
Innoviva, Inc.544KUS$11.4M2.4%
United Therapeutics Corporation21,361US$11.1M2.3%
Amphastar Pharmaceuticals, Inc.0US$00.00%

Source

View original at SEC

Related